Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcriptional adaptor 1 (TADA1) is a 335-amino acid nuclear protein, widely expressed across tissues, and is a member of the STAGA transcription coactivator–HAT complex. Its primary function is in the regulation of transcription, likely by facilitating histone acetylation and enhancing gene activation by RNA polymerase II. While TADA1 is frequently studied for its role in basic transcriptional mechanisms and is found as a fusion gene in some cancers—including lung adenocarcinoma—it is not currently considered a therapeutic target and no drugs directly interact with it. Its main significance is scientific, relating to chromatin biology and transcription regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcriptional adaptor 1 (TADA1).